NorthWest Biotherapeutics Inc (NWBO)

[Chiugray]

My gut understanding is clear:
The Wolf Pack gambled against NWBO’s resilience and lost.

For years, it feels like the Wolf pack was strong enough to be destructive, partially:
- Documented spoofing (and a variety of other nefarious activities IMO)
- A multi-year bear raid on the stock price
- Forcing a “penny stock” label onto NWBO (a true “diamond in the ruff”)

But, they were just NOT strong enough:
- Failed to impose their usual playbook of sabotage tactics onto NWBO
- Failed to deploy Trojan horse investors and lenders with crippling terms, like full-ratchet anti-dilution financing.
- Thus, they failed to create the death spiral of continual diluting and reverse split events.
- Most importantly, they couldn’t stop the company from making real, on-the-ground progress.

We know this because, NWBO, did the seemingly impossible. They were frugal and still accomplished great, major things:
- Built an entire state-of-art mfg facility (Sawston)
- Successfully completed the global Phase 3 clinical trial on the most difficult cancer (GBM) and the hardest metric (the gold standard of overall survival)
- Acquired Flaskworks.
- Acquired Roswell Park’s entire DC technology portfolio.
- and many other things…

Even recent financing confirms this resilience, as in the Streeterville debt financing, with straight interest, no warrants, and no “vulture” debt financing terms.

And it all leads to this truth: this scientific and corporate achievement works, is better, and is for cancer patients, and is already supported by oncologists. Soon, I believe, we shall see it supported by a mighty herd of financial whales and institutional investors who recognize the same.